R. Scott Greer is currently Managing Director of Numenor Ventures, LLC, where he has made direct investments in nearly twenty healthcare, technology, and consumer product companies. Mr. Greer founded Abgenix, Inc., a biotechnology company focused on developing human antibody-based therapeutics. He served as Abgenix's Chief Executive Officer from 1996 to 2002, and its Chairman from 2000 to 2006 when the company was acquired by Amgen, Inc. for approximately $2.2 billion. Mr. Greer invested in and served as Chairman of the Board of Sirna Therapeutics, a publicly-traded biotechnology company that was sold to Merck for more than $1.1 billion in December 2006. Prior to forming Abgenix, Mr. Greer spent five years at Cell Genesys, Inc., initially as Chief Financial Officer and Vice President of Corporate Development and later as Senior Vice President of Corporate Development. Mr. Greer is currently Chairman of the Board of Acologix, Inc., a development-stage biotechnology company and in the past has served on the boards of numerous public and private life sciences companies.
R. Scott Greer